MavriX Bio Announces FDA Clearance for Gene Therapy Trial
MavriX will initiate a clinical trial of a gene therapy for Angelman syndrome.
Capstan Therapeutics Begins Phase 1 Trial of CAR-T Therapy for Autoimmune Disease
Capstan Therapeutics, a biotechnology company spun out of Penn, has initiated its Phase 1 trial of an in vivo CAR-T therapy.
REGENXBIO’s Gene Therapy Updates for Hunter Syndrome and DMD
REGENXBIO was co-founded by James M. Wilson, MD, PhD, the Rose H. Weiss Orphan Disease Center Director's Professor in Penn Medicine.
Vivodyne Raises $40 Million to Advance Human Tissue Testing Platform
Vivodyne was co-founded by Dan Huh, PhD, Professor of Bioengineering in Penn Engineering and CEO Andrei Georgescu.,
Research at Penn Report Highlights the Global Impact of Penn’s Research
Penn has over 5,000 research faculty spanning 200+ centers.
Philadelphia Ranks #13 Globally, Climbing Up 12 Spots, in 2025 Global Startup Ecosystem Report
The 2025 Global Startup Ecosystem Report has been released.
World’s First Patient Treated with Personalized CRISPR Gene Editing Therapy through Penn Medicine and CHOP Collaboration
In a history-making breakthrough, a baby diagnosed with a rare genetic disorder was successfully treated with a customized CRISPR gene editing therapy.
Penn Engineering Hosts “AI at the Crossroads: Ethics, Innovation & Impact” During Philly Tech Week
Melissa Kelly, PhD, Deputy Managing Director of PCI, served as a panelist and shared her insights on the impact of AI.
AI Across Disciplines Event Highlights Penn’s Role in Shaping AI
At a cross-disciplinary gathering at Amy Gutmann Hall, the Penn community celebrated the launch of the Penn AI Initiative with a panel discussing AI research at Penn.
Penn Medicine’s Jake Brenner Develops State-of-the-art DNA-Delivery Technology
By safely delivering therapeutic DNA to cells, this technology has the potential to transform treatment for common chronic diseases.